Stockreport

MapLight Therapeutics Announces Pricing of Initial Public Offering

MapLight Therapeutics, Inc.  (MPLT) 
PDF SAN FRANCISCO and BOSTON, Oct. 26, 2025 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of p [Read more]